Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine receptor pharmacology

P Seeman1, H H Van Tol

  • 1Department of Pharmacology, University of Toronto, Ontario, Canada.

Current Opinion in Neurology and Neurosurgery
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients.

Scientific reports·2021
Same author

Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.

European journal of neurology·2020
Same author

Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.

Clinical genetics·2018
Same author

Charcot-Marie-Tooth 1A: Heterozygous T118M Mutation over a CMT1A Duplication Has No Influence on the Phenotype.

Annals of the New York Academy of Sciences·2017
Same author

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.

Translational psychiatry·2016
Same author

HSMNR belongs to the most frequent types of hereditary neuropathy in the Czech Republic and is twice more frequent than HMSNL.

Clinical genetics·2016

Discovering dopamine receptors aids in developing new antipsychotic and antiparkinson drugs. The dopamine D4 receptor and its variants show promise for targeted antipsychotic therapies, potentially through D2 or D4 receptor blockade.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Antipsychotic drugs were instrumental in the initial discovery of dopamine receptors.
  • Five distinct dopamine receptor subtypes (D1-D5) have been identified and cloned.
  • Understanding dopamine receptor subtypes is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To explore the differential sensitivities of dopamine receptor subtypes to various drugs.
  • To investigate the role of dopamine D4 receptor variants in antipsychotic drug action.
  • To determine the potential of dopamine D2 and D4 receptor blockade for antipsychotic effects.

Main Methods:

  • Review of existing literature on dopamine receptor pharmacology.
  • Analysis of drug binding affinities and sensitivities across D1-like (D1, D5) and D2-like (D2, D3, D4) receptors.

Related Experiment Videos

  • Examination of human dopamine D4 receptor variants and their sensitivity to clozapine.

    • Main Results:

    • Dopamine D5 receptors exhibit higher sensitivity to dopamine than D1 receptors.
    • Dopamine D4 receptors show distinct binding profiles compared to D2 and D3 receptors, particularly with clozapine.
    • Human D4 receptor variants (D4.2, D4.4, D4.7) demonstrate similar clozapine sensitivities within therapeutic concentration ranges.

    Conclusions:

    • The identified dopamine receptor subtypes offer opportunities for discovering more selective drugs.
    • Antipsychotic action may be mediated by the blockade of either dopamine D2 or D4 receptors.
    • The dopamine D4 receptor, especially its variants, represents a potential target for novel antipsychotic therapies.